Abstract
The longer survival of neoplastic patients achieved through improvements of therapeutic regimens has increased the relative risk of developing a second primary tumour (SPT). In this context, conventional cytopathology can define tumour histotype only in a small fraction of cases. In this study, we have evaluated whether selected combinations of monoclonal antibodies (MAbs) to tumour-associated antigens (TAAs) can increase the accuracy of conventional morphology in detecting second primary tumours (SPTs) in two particularly difficult areas of cytodiagnosis, namely that of effusions and pulmonary fine-needle aspirates (FNAs). The immunocytochemical (ICC) analysis of 334 cytological specimens demonstrated that the use of our selected panel of MAbs could allow a more efficient identification of SPTs in comparison with conventional morphology. This diagnostic improvement was statistically significant (P < 0.0001). The present findings show that the immunophenotyping of effusions and FNAs, providing a more accurate and objective identification of SPTs, may have significant therapeutic and epidemiological relevance.
Full text
PDF






Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abernathy D., Beltran G., Stuckey W. J. Lung cancer following treatment for lymphoma. Am J Med. 1986 Aug;81(2):215–218. doi: 10.1016/0002-9343(86)90254-8. [DOI] [PubMed] [Google Scholar]
- Canevari S., Fossati G., Balsari A., Sonnino S., Colnaghi M. I. Immunochemical analysis of the determinant recognized by a monoclonal antibody (MBr1) which specifically binds to human mammary epithelial cells. Cancer Res. 1983 Mar;43(3):1301–1305. [PubMed] [Google Scholar]
- Colcher D., Hand P. H., Nuti M., Schlom J. A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc Natl Acad Sci U S A. 1981 May;78(5):3199–3203. doi: 10.1073/pnas.78.5.3199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cooper J. S., Pajak T. F., Rubin P., Tupchong L., Brady L. W., Leibel S. A., Laramore G. E., Marcial V. A., Davis L. W., Cox J. D. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys. 1989 Sep;17(3):449–456. doi: 10.1016/0360-3016(89)90094-1. [DOI] [PubMed] [Google Scholar]
- Friedman M., Shimaoka K., Fox S., Panahon A. M. Second malignant tumors detected by needle aspiration cytology. Cancer. 1983 Aug 15;52(4):699–706. doi: 10.1002/1097-0142(19830815)52:4<699::aid-cncr2820520423>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
- Gallee M. P., van Vroonhoven C. C., van der Korput H. A., van der Kwast T. H., ten Kate F. J., Romijn J. C., Trapman J. Characterization of monoclonal antibodies raised against the prostatic cancer cell line PC-82. Prostate. 1986;9(1):33–45. doi: 10.1002/pros.2990090107. [DOI] [PubMed] [Google Scholar]
- Giacomini P., Segatto O., Natali P. G. Multiple epitope recognition: an approach to improved radioimmunodetection of tumor-associated antigens. Int J Cancer. 1987 Jun 15;39(6):729–736. doi: 10.1002/ijc.2910390613. [DOI] [PubMed] [Google Scholar]
- Giardini R., Martelli G., Rilke F., Pilotta S. Diagnostic problems of second primary malignancies detected by fine-needle aspiration cytology. Cancer. 1993 Nov 1;72(9):2716–2722. doi: 10.1002/1097-0142(19931101)72:9<2716::aid-cncr2820720932>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
- Golub G. R., Lefemine A. A. Multiple malignancies in lymphoproliferative disorders diagnosed by needle aspiration biopsy of pulmonary lesions. Cancer. 1969 Mar;23(3):725–729. doi: 10.1002/1097-0142(196903)23:3<725::aid-cncr2820230328>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
- Gown A. M., Vogel A. M., Hoak D., Gough F., McNutt M. A. Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. Am J Pathol. 1986 May;123(2):195–203. [PMC free article] [PubMed] [Google Scholar]
- Hainsworth J. D., Wright E. P., Johnson D. H., Davis B. W., Greco F. A. Poorly differentiated carcinoma of unknown primary site: clinical usefulness of immunoperoxidase staining. J Clin Oncol. 1991 Nov;9(11):1931–1938. doi: 10.1200/JCO.1991.9.11.1931. [DOI] [PubMed] [Google Scholar]
- Hajdu S. I., Melamed M. R. Limitations of aspiration cytology in the diagnosis of primary neoplasms. Acta Cytol. 1984 May-Jun;28(3):337–345. [PubMed] [Google Scholar]
- Kaldor J. M., Day N. E., Band P., Choi N. W., Clarke E. A., Coleman M. P., Hakama M., Koch M., Langmark F., Neal F. E. Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries. Int J Cancer. 1987 May 15;39(5):571–585. doi: 10.1002/ijc.2910390506. [DOI] [PubMed] [Google Scholar]
- Koss L. G. Aspiration biopsy--a tool in surgical pathology. Am J Surg Pathol. 1988;12 (Suppl 1):43–53. [PubMed] [Google Scholar]
- McDonald S., Haie C., Rubin P., Nelson D., Divers L. D. Second malignant tumors in patients with laryngeal carcinoma: diagnosis, treatment, and prevention. Int J Radiat Oncol Biol Phys. 1989 Sep;17(3):457–465. doi: 10.1016/0360-3016(89)90095-3. [DOI] [PubMed] [Google Scholar]
- Miotti S., Canevari S., Ménard S., Mezzanzanica D., Porro G., Pupa S. M., Regazzoni M., Tagliabue E., Colnaghi M. I. Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity. Int J Cancer. 1987 Mar 15;39(3):297–303. doi: 10.1002/ijc.2910390306. [DOI] [PubMed] [Google Scholar]
- Mottolese M., Venturo I., Benevolo M., Di Filippo F., Lopez M., Bigotti A., Natali P. G. Immunocytochemical diagnosis of amelanotic metastatic melanoma using monoclonal antibodies HMB-45 and Ep1-3. Melanoma Res. 1994 Feb;4(1):53–58. doi: 10.1097/00008390-199402000-00008. [DOI] [PubMed] [Google Scholar]
- Mottolese M., Venturo I., Digiesi G., Perrone Donnorso R., Bigotti A., Muraro R., Aluffi A., Natali P. G. Use of MoAb D612 in combination with a panel of MoAb for the immunocytochemical identification of metastases from colon-rectum carcinoma. Br J Cancer. 1990 Apr;61(4):626–630. doi: 10.1038/bjc.1990.139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mottolese M., Venturo I., Donnorso R. P., Curcio C. G., Rinaldi M., Natali P. G. Use of selected combinations of monoclonal antibodies to tumor associated antigens in the diagnosis of neoplastic effusions of unknown origin. Eur J Cancer Clin Oncol. 1988 Aug;24(8):1277–1284. doi: 10.1016/0277-5379(88)90215-5. [DOI] [PubMed] [Google Scholar]
- Mottolese M., Venturo I., Salzano M., Benevolo M., Bigotti A., Natali P. G. Immunocytodiagnosis of solid tumors employing panels of monoclonal antibodies. J Clin Lab Anal. 1993;7(4):238–242. doi: 10.1002/jcla.1860070409. [DOI] [PubMed] [Google Scholar]
- Muraro R., Nuti M., Natali P. G., Bigotti A., Simpson J. F., Primus F. J., Colcher D., Greiner J. W., Schlom J. A monoclonal antibody (D612) with selective reactivity for malignant and normal gastro-intestinal epithelium. Int J Cancer. 1989 Apr 15;43(4):598–607. doi: 10.1002/ijc.2910430411. [DOI] [PubMed] [Google Scholar]
- Nouwen E. J., Pollet D. E., Eerdekens M. W., Hendrix P. G., Briers T. W., De Broe M. E. Immunohistochemical localization of placental alkaline phosphatase, carcinoembryonic antigen, and cancer antigen 125 in normal and neoplastic human lung. Cancer Res. 1986 Feb;46(2):866–876. [PubMed] [Google Scholar]
- Oosterwijk E., Ruiter D. J., Wakka J. C., Huiskens-van der Meij J. W., Jonas U., Fleuren G. J., Zwartendijk J., Hoedemaeker P., Warnaar S. O. Immunohistochemical analysis of monoclonal antibodies to renal antigens. Application in the diagnosis of renal cell carcinoma. Am J Pathol. 1986 May;123(2):301–309. [PMC free article] [PubMed] [Google Scholar]
- Perry M. D., Seigler H. F., Johnston W. W. Diagnosis of metastatic malignant melanoma by fine needle aspiration biopsy: a clinical and pathologic correlation of 298 cases. J Natl Cancer Inst. 1986 Nov;77(5):1013–1021. [PubMed] [Google Scholar]
- Pilotti S., Di Palma S., Alasio L., Bartoli C., Rilke F. Diagnostic assessment of enlarged superficial lymph nodes by fine needle aspiration. Acta Cytol. 1993 Nov-Dec;37(6):853–866. [PubMed] [Google Scholar]
- Thor A., Ohuchi N., Szpak C. A., Johnston W. W., Schlom J. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res. 1986 Jun;46(6):3118–3124. [PubMed] [Google Scholar]
- Tucker M. A., Coleman C. N., Cox R. S., Varghese A., Rosenberg S. A. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med. 1988 Jan 14;318(2):76–81. doi: 10.1056/NEJM198801143180203. [DOI] [PubMed] [Google Scholar]
- van der Gaast A., Verwij J., Planting A. S., Stoter G., Henzen-Logmans S. C. The value of immunohistochemistry in patients with poorly differentiated adenocarcinomas and undifferentiated carcinomas of unknown primary. J Cancer Res Clin Oncol. 1996;122(3):181–185. doi: 10.1007/BF01366960. [DOI] [PMC free article] [PubMed] [Google Scholar]
